Nathsons Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 6.50 M
as on 26-06-2024
- Paid Up Capital ₹ 3.43 M
as on 26-06-2024
- Company Age 33 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 36.93 M
as on 26-06-2024
- Satisfied Charges ₹ 16.00 M
as on 26-06-2024
- Revenue 4.54%
(FY 2022)
- Profit 129.92%
(FY 2022)
- Ebitda -325.99%
(FY 2022)
- Net Worth 14.44%
(FY 2022)
- Total Assets 61.19%
(FY 2022)
About Nathsons Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.50 M and a paid-up capital of Rs 3.43 M.
The company currently has active open charges totaling ₹3.69 Cr. The company has closed loans amounting to ₹1.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sudhir Goyal and Madhu Goyal serve as directors at the Company.
- CIN/LLPIN
U74899DL1991PTC045508
- Company No.
045508
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Aug 1991
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Central Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Nathsons Pharmaceuticals Private Limited offer?
Nathsons Pharmaceuticals Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Corona Test Kit, Nutraceuticals & Dietary Supplements, Nutritional Supplements, Anti Infective Drugs & Medicines, Antiviral Drugs, Rapid Test Kit.
Who are the key members and board of directors at Nathsons Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudhir Goyal  | Managing Director | 29-Aug-1991 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madhu Goyal | Whole-Time Director | 24-Aug-2007 | Current |
Financial Performance and Corporate Structure Insights of Nathsons Pharmaceuticals.
Nathsons Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 4.54% increase. The company also saw a substantial improvement in profitability, with a 129.92% increase in profit. The company's net worth Soared by an impressive increase of 14.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nathsons Pharmaceuticals?
In 2020, Nathsons Pharmaceuticals had a promoter holding of 99.63% and a public holding of 0.37%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 01 Feb 2022 | ₹4.40 M | Open |
Bank Of Baroda Creation Date: 11 Jun 2012 | ₹0.90 M | Open |
Bank Of Baroda Creation Date: 12 May 2012 | ₹0.35 M | Open |
How Many Employees Work at Nathsons Pharmaceuticals?
Unlock and access historical data on people associated with Nathsons Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nathsons Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nathsons Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
